Sign in Subscribe
United States. Securities and Exchange Commission

Celsion Corp. Files SEC Form 4, Compliance with SEC Regulations

Strategic Insights

— 1 min read

Celsion Corp. has fulfilled its regulatory obligations by submitting a Form 4 filing with the U.S. Securities and Exchange Commission (SEC). This filing is a mandatory requirement for companies, as per the guidelines set forth in the Securities Exchange Act of 1934. The submission on August 7, 2015, marks a significant milestone in the company's compliance with SEC regulations.

The SEC Form 4 filing provides detailed information regarding the company's dealings with equity securities, including purchases, sales, and changes in ownership. This formal document is a testament to Celsion Corp.'s commitment to transparency and adherence to regulatory standards.

Key Takeaways:

  • The filing was made by Celsion Corp. on August 7, 2015, as required by the SEC.
  • The filing pertains to the company's compliance with Section 12 of the Securities Exchange Act of 1934.
  • The SEC Form 4 filing contains information about Celsion Corp.'s relationship with the company, including purchases and sales of equity securities.
  • This filing is a mandatory requirement for directors, officers, and owners with more than ten percent ownership in a class of equity securities registered under the SEC's regulations.
  • The company's SEC file number is 0001144204-15-047217, and the contact information is listed as 997 Lenox Drive, Suite 100, Lawrenceville, NJ 08648, with a phone number of (609) 896-9100.

Statistics:

  • The SIC code for Celsion Corp. is 2834, indicating its primary business as Pharmaceutical Preparations.
  • The company has submitted one document with the SEC Form 4 filing.
  • The submission was made on August 7, 2015, in compliance with SEC regulations.
  • The Annual Statement of beneficial ownership of securities for Celsion Corp. is reported on Form 5.

Sources:

  • U.S. Securities and Exchange Commission (SEC) filing, Celsion Corp. (Form 4), August 7, 2015.
  • "U.S. Securities and Exchange Commission filing is a formal document or financial statement submitted to the SEC by publicly-traded companies."
  • NewsRx, "Pharmaceutical Preparations, SEC Filing, Celsion Corporation, Biotechnology Companies".

Read more